Communiqués Hisamitsu Pharmaceutical Co., Inc.

Actions

4530

JP3784600003

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
3 975 ^JPY	+0,53 %		+6,63 %	-7,79 %

11/07	Hisamitsu Pharmaceutical Co. présente ses prévisions de résultats consolidés pour l'exercice fiscal se terminant le 28 février 2025	CI
23/05	Hisamitsu Pharmaceutical Co. (TSE:4530) annonce un rachat d'actions pour 2.400.000 actions, représentant 3,17%, pour un montant de 8.901,6 millions ¥.	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders	25/04	PU
Hisamitsu Pharmaceutical : Earning Document	11/04	PU
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”	13/03	PU
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	05/12	PU
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.	31/10/23	PU
Hisamitsu Pharmaceutical : Earning Document	06/10/23	PU
Hisamitsu Pharmaceutical : Earning Document	06/10/23	PU
Hisamitsu Pharmaceutical : Notification regarding Skin Care Cosmetics with Microneedle Technology	20/09/23	PU
Hisamitsu Pharmaceutical : Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)	19/09/23	PU
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	04/09/23	PU
Hisamitsu Pharmaceutical : Products to solve issues for living in Space and living on Earth “Odorleship®” Notification to be used in the International Space Station	28/08/23	PU
Hisamitsu Pharmaceutical : Notice regarding Determination of Details of Issuance of Stock Compensation-Type Share Options (Stock Acquisition Rights)	31/07/23	PU
Hisamitsu Pharmaceutical : Notice regarding Providing Relief Supplies in Response to the Torrential Rains from July 7, 2023	27/07/23	PU
Hisamitsu Pharmaceutical : Notification Regarding Concerning the Decision of Matters Relating to Acquisition of Company’s Own Shares	13/07/23	PU
Hisamitsu Pharmaceutical : Conclusion of a contract with SSP Co., Ltd. for the partial transfer of assets, related to S-Cup and Lacalut	13/07/23	PU
Hisamitsu Pharmaceutical : Earning Document	13/07/23	PU
Hisamitsu Pharmaceutical : Earning Document	13/07/23	PU
Hisamitsu Pharmaceutical : Notice regarding Issuance of Stock Compensation-Type Share Options	13/07/23	PU
Hisamitsu Pharmaceutical : Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Seventh Consecutive Year	18/05/23	PU
Hisamitsu Pharmaceutical : Notice of Convocation of the 121th Annual General Meeting of Shareholders	26/04/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Hisamitsu Pharmaceutical Co., Inc.

Actions

4530

JP3784600003

Communiqués

Filtres